. . . . . . . . . . . . . "a(CHEBI:lipopolysaccharide) -| r(RGD:Cyp4f4)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "To examine hepatic totipotency, primary hepatocytes were treated with varying doses of LPS resulting in decrease in all the CYP4F isoforms. Treatment of hepatocytes with 5 ng/ml of interleukin-1beta mimics the in vivo effects of LPS on CYP4F expression." . . "Selventa" . . . . "2014-07-03T14:30:18.638+02:00"^^ . . .